ENHANCED NITRIC-OXIDE SYNTHASE ACTIVITY IN PORTAL HYPERTENSIVE RABBITS

被引:86
作者
CAHILL, PA [1 ]
FOSTER, G [1 ]
REDMOND, EM [1 ]
GINGALEWSKI, C [1 ]
WU, YP [1 ]
SITZMANN, JV [1 ]
机构
[1] JOHNS HOPKINS MED INST,DEPT SURG,BALTIMORE,MD 21205
关键词
D O I
10.1016/0270-9139(95)90585-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Portal hypertension (PHT) is characterized by splanchnic hyperemia caused by a reduction in mesenteric vascular resistance. Mediators of this hyperemia include nitric oxide (NO), This is based on several reports indicating a marked splanchnic hyporesponsiveness in PHT to vasoconstrictor stimuli, both in vitro and in vivo, and a subsequent reversal using specific inhibitors of NO synthase (NOS). The objective of this study was to determine directly if the generation of NO is altered in PHT vasculature. Thus, we compared NOS activity in the hyperemic vasculature of normal rabbits and rabbits with PHT (after undergoing partial portal vein ligation). Nicotinamide adenine dinucleotide phosphate diaphorase staining indicated the presence of NOS within the vascular endothelium. Ca2+-dependent NOS activity was significantly increased (P < .05) in PHT particulate fractions from the superior mesenteric artery and thoracic aorta, but not from the portal vein, There was no change in NOS activity within the cytosolic fractions, Arterial wall cyclic guanosine monophosphate (cGMP) levels and plasma nitrite levels were both significantly increased in PHT. These results show enhanced NOS activity in PHT hyperemic vessels concurrent with increased tissue cGMP levels. We conclude that enhanced NO synthesis contributes to the hyperdynamic circulation of PHT.
引用
收藏
页码:598 / 606
页数:9
相关论文
共 43 条
  • [1] HEPATIC CIRCULATION - POTENTIAL FOR THERAPEUTIC INTERVENTION
    BALLET, F
    [J]. PHARMACOLOGY & THERAPEUTICS, 1990, 47 (02) : 281 - 328
  • [2] ROLE OF GLUCAGON IN SPLANCHNIC HYPEREMIA OF CHRONIC PORTAL-HYPERTENSION
    BENOIT, JN
    ZIMMERMAN, B
    PREMEN, AJ
    GO, VLW
    GRANGER, DN
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1986, 251 (05): : G674 - G677
  • [3] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [4] ISOLATION OF NITRIC-OXIDE SYNTHETASE, A CALMODULIN-REQUIRING ENZYME
    BREDT, DS
    SNYDER, SH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (02) : 682 - 685
  • [5] CLONED AND EXPRESSED NITRIC-OXIDE SYNTHASE STRUCTURALLY RESEMBLES CYTOCHROME-P-450 REDUCTASE
    BREDT, DS
    HWANG, PM
    GLATT, CE
    LOWENSTEIN, C
    REED, RR
    SNYDER, SH
    [J]. NATURE, 1991, 351 (6329) : 714 - 718
  • [6] BRODDE OE, 1992, J HYPERTENS, V10, pS133
  • [7] SHEAR-STRESS INDUCED RELEASE OF NITRIC-OXIDE FROM ENDOTHELIAL-CELLS GROWN ON BEADS
    BUGA, GM
    GOLD, ME
    FUKUTO, JM
    IGNARRO, LJ
    [J]. HYPERTENSION, 1991, 17 (02) : 187 - 193
  • [8] ALTERED ADENYLYL-CYCLASE ACTIVITIES AND G-PROTEIN ABNORMALITIES IN PORTAL HYPERTENSIVE RABBITS
    CAHILL, PA
    WU, YP
    SITZMANN, JV
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (06) : 2691 - 2700
  • [9] GUANOSINE 3',5'-CYCLIC-MONOPHOSPHATE ASSAY AT 10-15-MOLE LEVEL
    CAILLA, HL
    VANNIER, CJ
    DELAAGE, MA
    [J]. ANALYTICAL BIOCHEMISTRY, 1976, 70 (01) : 195 - 202
  • [10] IMPAIRED RESPONSIVENESS TO ANGIOTENSIN-II IN EXPERIMENTAL CIRRHOSIS - ROLE OF NITRIC-OXIDE
    CASTRO, A
    JIMENEZ, W
    CLARIA, J
    ROS, J
    MARTINEZ, JM
    BOSCH, M
    ARROYO, V
    PIULATS, J
    RIVERA, F
    RODES, J
    [J]. HEPATOLOGY, 1993, 18 (02) : 367 - 372